Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8772)
All Articles published online
|
Apr 7, 2009 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
De BK, Gangopadhyay S, Dutta D, Baksi SD, Pani A, Ghosh P. Pentoxifylline |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i13/1613.htm |
| Number | Citing Articles |
| 1 |
Umair Sohail, Sanjaya K. Satapathy. Diagnosis and Management of Alcoholic Hepatitis. Clinics in Liver Disease 2012; 16(4): 717 doi: 10.1016/j.cld.2012.08.005
|
| 2 |
Moon-Sun Kim, Madeleine Ong, Xianqin Qu. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?. World Journal of Gastroenterology 2016; 22(1): 8-23 doi: 10.3748/wjg.v22.i1.8
|
| 3 |
Juan Caballeria. Is there a role for pentoxifylline in the treatment of alcoholic hepatitis?. Gastroenterología y Hepatología (English Edition) 2016; 39(8): 560 doi: 10.1016/j.gastre.2016.07.004
|
| 4 |
Francesco Giuseppe Foschi, Fabio Caputo, Anna Chiara Dall’Aglio, Giorgio Zoli, Mauro Bernardi, Francesco Chiappellli, Giuseppe Francesco Stefanini. Evidence-Based Practice: Toward Optimizing Clinical Outcomes. 2010; : 173 doi: 10.1007/978-3-642-05025-1_11
|
| 5 |
Tom Luedde, Neil Kaplowitz, Robert F. Schwabe. Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance. Gastroenterology 2014; 147(4): 765 doi: 10.1053/j.gastro.2014.07.018
|
| 6 |
Alexandre Louvet, Mark R. Thursz, Dong Joon Kim, Julien Labreuche, Stephen R. Atkinson, Sandeep Singh Sidhu, John G. O’Grady, Evangelos Akriviadis, Emmanouil Sinakos, Robert L. Carithers, Marie-José Ramond, Willis C. Maddrey, Timothy R. Morgan, Alain Duhamel, Philippe Mathurin. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo—a Meta-analysis of Individual Data From Controlled Trials. Gastroenterology 2018; 155(2): 458 doi: 10.1053/j.gastro.2018.05.011
|
| 7 |
Ashwani K Singal, Ishmeet Walia, Anjna Singal, Roger D Soloway. Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: Current status. World Journal of Hepatology 2011; 3(8): 205-210 doi: 10.4254/wjh.v3.i8.205
|
| 8 |
Josiah E. Hardesty, Craig J. McClain. Current Pharmacotherapy and Nutrition Therapy of Alcohol-Associated Liver Disease. Clinics in Liver Disease 2024; 28(4): 731 doi: 10.1016/j.cld.2024.06.018
|
| 9 |
Elena Buzzetti, Maria Kalafateli, Douglas Thorburn, Brian R Davidson, Maja Thiele, Lise Lotte Gluud, Cinzia Del Giovane, Gro Askgaard, Aleksander Krag, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease). Cochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD011646.pub2
|
| 10 |
B. Dupont, T. Dao, M. -A. Piquet. Hépatite alcoolique aiguë : prise en charge en 2011. Réanimation 2011; 20(4): 335 doi: 10.1007/s13546-011-0276-5
|
| 11 |
Patricia E. Molina, Jason D. Gardner, Flavia M. Souza-Smith, Annie M. Whitaker. Alcohol Abuse: Critical Pathophysiological Processes and Contribution to Disease Burden. Physiology 2014; 29(3): 203 doi: 10.1152/physiol.00055.2013
|
| 12 |
Ashwani K. Singal, Sudha Kodali, Lee A. Vucovich, Victor Darley-Usmar, Thomas D. Schiano. Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review. Alcoholism: Clinical and Experimental Research 2016; 40(7): 1390 doi: 10.1111/acer.13108
|
| 13 |
K.J. Senthil Kumar, Fang-Hua Chu, Han-Wen Hsieh, Jiunn-Wang Liao, Wen-Hsiung Li, Johnson Chin-Chung Lin, Jei-Fu Shaw, Sheng-Yang Wang. Antroquinonol from ethanolic extract of mycelium of Antrodia cinnamomea protects hepatic cells from ethanol-induced oxidative stress through Nrf-2 activation. Journal of Ethnopharmacology 2011; 136(1): 168 doi: 10.1016/j.jep.2011.04.030
|
| 14 |
Yingfeng Tu, Shu Zhu, Jing Wang, Ezra Burstein, Da Jia. Natural compounds in the chemoprevention of alcoholic liver disease. Phytotherapy Research 2019; 33(9): 2192 doi: 10.1002/ptr.6410
|
| 15 |
Fangfang Duan, Chen Liu, Chunyan Chang, Shanshan Song, Hang Zhai, Jun Cheng, Song Yang. Granulocyte colony-stimulating factor plus pentoxifylline increases short-term survival in patients with severe alcoholic hepatitis: a network meta-analysis. The American Journal of Drug and Alcohol Abuse 2024; 50(2): 191 doi: 10.1080/00952990.2023.2266117
|
| 16 |
Philippe Mathurin, Michael R. Lucey. Management of alcoholic hepatitis. Journal of Hepatology 2012; 56: S39 doi: 10.1016/S0168-8278(12)60005-1
|
| 17 |
Ashwani K. Singal, Patrick S. Kamath, Gregory J. Gores, Vijay H. Shah. Alcoholic Hepatitis: Current Challenges and Future Directions. Clinical Gastroenterology and Hepatology 2014; 12(4): 555 doi: 10.1016/j.cgh.2013.06.013
|
| 18 |
Mack C. Mitchell, Lawrence S. Friedman, Craig J. McClain. Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute. Clinical Gastroenterology and Hepatology 2017; 15(1): 5 doi: 10.1016/j.cgh.2016.08.047
|
| 19 |
Rakhi Maiwall, S. K. Sarin, Richard Moreau. Acute kidney injury in acute on chronic liver failure. Hepatology International 2016; 10(2): 245 doi: 10.1007/s12072-015-9652-y
|
| 20 |
Shiv K. Sarin, Ashok Choudhury. Acute-on-chronic liver failure: terminology, mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2016; 13(3): 131 doi: 10.1038/nrgastro.2015.219
|
| 21 |
Srinivasan Dasarathy, Mack C. Mitchell, Bruce Barton, Craig J. McClain, Gyongyi Szabo, Laura E. Nagy, Svetlana Radaeva, Arthur J. McCullough. Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis. Contemporary Clinical Trials 2020; 96: 106094 doi: 10.1016/j.cct.2020.106094
|
| 22 |
Young-Sun Lee, Hyun Jung Kim, Ji Hoon Kim, Yang Jae Yoo, Tae Suk Kim, Seong Hee Kang, Sang Jun Suh, Moon Kyung Joo, Young Kul Jung, Beom Jae Lee, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Jae Seon Kim, Jong-Jae Park, Soon Ho Um, Young-Tae Bak, Kwan Soo Byun. Treatment of Severe Alcoholic Hepatitis With Corticosteroid, Pentoxifylline, or Dual Therapy. Journal of Clinical Gastroenterology 2017; 51(4): 364 doi: 10.1097/MCG.0000000000000674
|
| 23 |
Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang. Revision and update on clinical practice guideline for liver cirrhosis. The Korean Journal of Hepatology 2012; 18(1): 1 doi: 10.3350/kjhep.2012.18.1.1
|
| 24 |
Jolene Siple, Lynnette Klaus, Kathryn S. Voll. Alcoholic hepatitis in a patient with a history of daily beer consumption. Journal of the American Academy of Physician Assistants 2010; 23(11): E1 doi: 10.1097/01720610-201011000-00024
|
| 25 |
Robin Arora, Shweta Kathuria, Nishant Jalandhara. Acute renal dysfunction in patients with alcoholic hepatitis. World Journal of Hepatology 2011; 3(5): 121-124 doi: 10.4254/wjh.v3.i5.121
|
| 26 |
Fátima Higuera-de la Tijera, Alfredo Israel Servín-Caamaño, Eduardo Pérez-Torres, Francisco Salas-Gordillo, Juan Miguel Abdo-Francis, José Luis Pérez-Hernández, David Kershenobich. Main clinical factors influencing early mortality in a cohort of patients with severe alcoholic hepatitis, and evaluation trough ROC curves of different prognostic scoring systems. Revista Médica Del Hospital General De México 2014; 77(4): 160 doi: 10.1016/j.hgmx.2014.10.003
|
| 27 |
Juliane I. Beier, Craig J. McClain. Mechanisms and cell signaling in alcoholic liver disease. Biological Chemistry 2010; 391(11) doi: 10.1515/bc.2010.137
|
| 28 |
Ashwani K Singal, Ramon Bataller, Joseph Ahn, Patrick S Kamath, Vijay H Shah. ACG Clinical Guideline: Alcoholic Liver Disease. American Journal of Gastroenterology 2018; 113(2): 175 doi: 10.1038/ajg.2017.469
|
| 29 |
Jan Petrasek, Gyongyi Szabo. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 291 doi: 10.1007/978-3-319-20538-0_15
|
| 30 |
Francisco J. Bosques-Padilla, Genaro Vázquez-Elizondo, Manuel A. Martínez Vázquez, Héctor J. Maldonado-Garza. Pentoxifylline and prednisolone in severe alcoholic hepatitis. Annals of Hepatology 2009; 8(4): 402 doi: 10.1016/S1665-2681(19)31760-0
|
| 31 |
A.M. Müller-Marbach, D. Häussinger, L.C. Rump, O. Vonend. Das hepatorenale Syndrom. Der Nephrologe 2010; 5(1): 29 doi: 10.1007/s11560-009-0339-z
|
| 32 |
R. Parker, M. J. Armstrong, C. Corbett, I. A. Rowe, D. D. Houlihan. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis. Alimentary Pharmacology & Therapeutics 2013; 37(9): 845 doi: 10.1111/apt.12279
|
| 33 |
Ravi Daswani, Ashish Kumar, Shrihari Anil Anikhindi, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India. Indian Journal of Gastroenterology 2018; 37(2): 141 doi: 10.1007/s12664-018-0842-0
|
| 34 |
Ryan E. Owens, Heather S. Snyder, Jennifer D. Twilla, Sanjaya K. Satapathy. Pharmacologic Treatment of Alcoholic Hepatitis: Examining Outcomes Based on Disease Severity Stratification. Journal of Clinical and Experimental Hepatology 2016; 6(4): 275 doi: 10.1016/j.jceh.2016.07.003
|
| 35 |
Dolores Morrison, Justine Sgrillo, Lauren H. Daniels. Tratamiento de la hepatopatía alcohólica. Nursing (Ed. española) 2015; 32(4): 18 doi: 10.1016/j.nursi.2015.08.010
|
| 36 |
Basile Njei, Albert Do, Thomas R. McCarty, Brett E. Fortune. Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis. Journal of Clinical Gastroenterology 2016; 50(10): 871 doi: 10.1097/MCG.0000000000000585
|
| 37 |
Zhanxiang Zhou, Ross E. Jones, Craig J. McClain. HIV and Liver Disease. 2012; : 45 doi: 10.1007/978-1-4419-1712-6_6
|
| 38 |
Fátima Higuera-de la Tijera, Alfredo I Servín-Caamaño, Aurora E Serralde-Zúñiga, Javier Cruz-Herrera, Eduardo Pérez-Torres, Juan M Abdo-Francis, Francisco Salas-Gordillo, José L Pérez-Hernández. Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis. World Journal of Gastroenterology 2015; 21(16): 4975-4985 doi: 10.3748/wjg.v21.i16.4975
|
| 39 |
Eyad Gadour, Tamer Mohamed, Zeinab Hassan, Abdalla Hassan. Meta-Analysis and Systematic Review of Primary Renal Tubular Acidosis in Patients With Autoimmune Hepatitis and Alcoholic Hepatitis. Cureus 2021; doi: 10.7759/cureus.15287
|
| 40 |
Jennifer T. Wells, Michael R. Lucey. Textbook of Clinical Gastroenterology and Hepatology. 2012; : 649 doi: 10.1002/9781118321386.ch88
|
| 41 |
Partha Pal, Sayantan Ray. Alcoholic Liver Disease: A Comprehensive Review. European Medical Journal 2016; : 85 doi: 10.33590/emj/10312346
|
| 42 |
Ki Tae Suk, Moon Young Kim, Soon Koo Baik. Alcoholic liver disease: Treatment. World Journal of Gastroenterology 2014; 20(36): 12934-12944 doi: 10.3748/wjg.v20.i36.12934
|
| 43 |
Puiyan Lam, Fan Cheung, Hor Tan, Ning Wang, Man Yuen, Yibin Feng. Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities. International Journal of Molecular Sciences 2016; 17(4): 465 doi: 10.3390/ijms17040465
|
| 44 |
B. Javier Brahm, P. Rodrigo Quera. Síndrome hepatorenal: patogénesis y tratamiento. Revista Médica Clínica Las Condes 2010; 21(4): 613 doi: 10.1016/S0716-8640(10)70577-0
|
| 45 |
Laura Smart, Leila Gobejishvili, Neil Crittenden, Shirish Barve, Craig J. McClain. Alcoholic Hepatitis: Steroids vs. Pentoxifylline. Current Hepatitis Reports 2013; 12(1): 59 doi: 10.1007/s11901-012-0158-y
|
| 46 |
Laxman Singh, Tanuj Joshi, Devesh Tewari, Javier Echeverría, Andrei Mocan, Archana N. Sah, Emil Parvanov, Nikolay T. Tzvetkov, Zheng Feei Ma, Yeong Yeh Lee, Piotr Poznański, Lukasz Huminiecki, Mariusz Sacharczuk, Artur Jóźwik, Jarosław O. Horbańczuk, Joanna Feder-Kubis, Atanas G. Atanasov. Ethnopharmacological Applications Targeting Alcohol Abuse: Overview and Outlook. Frontiers in Pharmacology 2020; 10 doi: 10.3389/fphar.2019.01593
|
| 47 |
Ashwani K. Singal, Vijay H. Shah. Zakim and Boyer's Hepatology. 2018; : 351 doi: 10.1016/B978-0-323-37591-7.00024-0
|
| 48 |
Yoshinori Horie. Granulocytapheresis and plasma exchange for severe alcoholic hepatitis. Journal of Gastroenterology and Hepatology 2012; 27(s2): 99 doi: 10.1111/j.1440-1746.2011.07005.x
|
| 49 |
Ewan Forrest, Jane Mellor, Louise Stanton, Megan Bowers, Priscilla Ryder, Andrew Austin, Christopher Day, Dermot Gleeson, John O’Grady, Steven Masson, Anne McCune, David Patch, Paul Richardson, Paul Roderick, Stephen Ryder, Mark Wright, Mark Thursz. Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial. Trials 2013; 14(1) doi: 10.1186/1745-6215-14-262
|
| 50 |
Thomas H. Frazier, Abigail M. Stocker, Nicole A. Kershner, Luis S. Marsano, Craig J. McClain. Treatment of alcoholic liver disease. Therapeutic Advances in Gastroenterology 2011; 4(1): 63 doi: 10.1177/1756283X10378925
|
| 51 |
Gina Choi, Bruce Allen Runyon. Alcoholic Hepatitis: A Clinician’s Guide. Clinics in Liver Disease 2012; 16(2): 371 doi: 10.1016/j.cld.2012.03.015
|
| 52 |
Vassilios Papastergiou, Andrew K Burroughs, Emmanuel A Tsochatzis. Prognosis and treatment of patients with acute alcoholic hepatitis. Expert Review of Gastroenterology & Hepatology 2014; 8(5): 471 doi: 10.1586/17474124.2014.903800
|
| 53 |
Mark Thursz, Timothy R. Morgan. Treatment of Severe Alcoholic Hepatitis. Gastroenterology 2016; 150(8): 1823 doi: 10.1053/j.gastro.2016.02.074
|
| 54 |
Stefani Vircheva, Albena Alexandrova, Almira Georgieva, Polina Mateeva, Rositza Zamfirova, Marta Kubera, Margarita Kirkova. In vivo effects of pentoxifylline on enzyme and non‐enzyme antioxidant levels in rat liver after carrageenan‐induced paw inflammation. Cell Biochemistry and Function 2010; 28(8): 668 doi: 10.1002/cbf.1705
|
| 55 |
Ariel W. Aday, Mack C. Mitchell, Lisa C. Casey. Alcoholic hepatitis. Current Opinion in Gastroenterology 2017; 33(3): 142 doi: 10.1097/MOG.0000000000000359
|
| 56 |
Mark Thursz, Ewan Forrest, Paul Roderick, Christopher Day, Andrew Austin, John O’Grady, Stephen Ryder, Michael Allison, Dermot Gleeson, Anne McCune, David Patch, Mark Wright, Steven Masson, Paul Richardson, Luke Vale, Jane Mellor, Louise Stanton, Megan Bowers, Ian Ratcliffe, Nichola Downs, Scott Kirkman, Tara Homer, Laura Ternent. The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial. Health Technology Assessment 2015; 19(102): 1 doi: 10.3310/hta191020
|
| 57 |
Bin Gao, Ramon Bataller. Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets. Gastroenterology 2011; 141(5): 1572 doi: 10.1053/j.gastro.2011.09.002
|
| 58 |
A. Davenport, J. Ahmad, A. Al-Khafaji, J. A. Kellum, Y. S. Genyk, M. K. Nadim. Medical management of hepatorenal syndrome. Nephrology Dialysis Transplantation 2012; 27(1): 34 doi: 10.1093/ndt/gfr736
|
| 59 |
Rolf Teschke. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options. Expert Opinion on Pharmacotherapy 2018; 19(8): 779 doi: 10.1080/14656566.2018.1465929
|
| 60 |
EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease. Journal of Hepatology 2012; 57(2): 399 doi: 10.1016/j.jhep.2012.04.004
|
| 61 |
Sukhpreet Singh, Natalia A Osna, Kusum K Kharbanda. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World Journal of Gastroenterology 2017; 23(36): 6549-6570 doi: 10.3748/wjg.v23.i36.6549
|
| 62 |
Tao Zeng, Cui-Li Zhang, Mo Xiao, Rui Yang, Ke-Qin Xie. Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical Trials. Frontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00538
|
| 63 |
Wanzhu Tu, Samer Gawrieh, Srinivasan Dasarathy, Mack C. Mitchell, Douglas A. Simonetto, Kavish R. Patidar, Craig J. McClain, Ramon Bataller, Gyongyi Szabo, Qing Tang, Bruce A. Barton, Svetlana Radaeva, Arun J. Sanyal, Vijay Shah. Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis. Contemporary Clinical Trials Communications 2023; 32: 101074 doi: 10.1016/j.conctc.2023.101074
|
| 64 |
Lee Suan Chua. Review on Liver Inflammation and Antiinflammatory Activity of Andrographis paniculata for Hepatoprotection. Phytotherapy Research 2014; 28(11): 1589 doi: 10.1002/ptr.5193
|
| 65 |
Jonathan R Potts, Sumita Verma. Alcoholic hepatitis: diagnosis and management in 2012. Expert Review of Gastroenterology & Hepatology 2012; 6(6): 695 doi: 10.1586/egh.12.57
|
| 66 |
Vijay H. Shah. Alcoholic Liver Disease: the Buzz May Be Gone, But the Hangover Remains. Hepatology 2010; 51(5): 1483 doi: 10.1002/hep.23686
|
| 67 |
Jessica Williams, Wen-Xing Ding. A Mechanistic Review of Mitophagy and Its Role in Protection against Alcoholic Liver Disease. Biomolecules 2015; 5(4): 2619 doi: 10.3390/biom5042619
|
| 68 |
Diana V Avila, David F Barker, JingWen Zhang, Craig J McClain, Shirish Barve, Leila Gobejishvili. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol‐induced steatosis. The Journal of Pathology 2016; 240(1): 96 doi: 10.1002/path.4760
|
| 69 |
Juliane I. Beier, Gavin E. Arteel, Craig J. McClain. Advances in Alcoholic Liver Disease. Current Gastroenterology Reports 2011; 13(1): 56 doi: 10.1007/s11894-010-0157-5
|
| 70 |
Grzegorz Wystrychowski, Wojciech Wystrychowski, Władysław Grzeszczak, Andrzej Więcek, Robert Król, Antoni Wystrychowski. Pentoxifylline and Methylprednisolone Additively Alleviate Kidney Failure and Prolong Survival of Rats after Renal Warm Ischemia-Reperfusion. International Journal of Molecular Sciences 2018; 19(1): 221 doi: 10.3390/ijms19010221
|
| 71 |
Jeongeun Hyun, Zhaoli Sun, Ali Reza Ahmadi, Sushant Bangru, Ullas V. Chembazhi, Kuo Du, Tianyi Chen, Hidekazu Tsukamoto, Ivan Rusyn, Auinash Kalsotra, Anna Mae Diehl. Epithelial splicing regulatory protein 2–mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis. Journal of Clinical Investigation 2020; 130(4): 2129 doi: 10.1172/JCI132691
|
| 72 |
Gyongyi Szabo, Mack Mitchell, Craig J. McClain, Srinivasan Dasarathy, Bruce Barton, Arthur J. McCullough, Laura E. Nagy, Aimee Kroll‐Desrosiers, David Tornai, Hyesung Alice Min, Svetlana Radaeva, M. E. Blair Holbein, Lisa Casey, Jennifer Cuthbert. IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis. Hepatology 2022; 76(4): 1058 doi: 10.1002/hep.32478
|
| 73 |
Dolores Morrison, Justine Sgrillo, Lauren H. Daniels. Managing alcoholic liver disease. Nursing 2014; 44(11): 30 doi: 10.1097/01.NURSE.0000454950.13699.e0
|
| 74 |
Roopjeet K. Bath, George Y. Wu. Pocket Handbook of GI Pharmacotherapeutics. Clinical Gastroenterology 2016; : 113 doi: 10.1007/978-3-319-33317-5_8
|
| 75 |
Ahmad Nassar, Abed N. Azab. Effects of Dexamethasone and Pentoxifylline on Mania-like and Depression-like Behaviors in Rats. Pharmaceuticals 2022; 15(9): 1063 doi: 10.3390/ph15091063
|
| 76 |
Siddharth Singh, Mohammad Hassan Murad, Apoorva K. Chandar, Connie M. Bongiorno, Ashwani K. Singal, Stephen R. Atkinson, Mark R. Thursz, Rohit Loomba, Vijay H. Shah. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. Gastroenterology 2015; 149(4): 958 doi: 10.1053/j.gastro.2015.06.006
|
| 77 |
Mark R. Thursz, Paul Richardson, Michael Allison, Andrew Austin, Megan Bowers, Christopher P. Day, Nichola Downs, Dermot Gleeson, Alastair MacGilchrist, Allister Grant, Steven Hood, Steven Masson, Anne McCune, Jane Mellor, John O’Grady, David Patch, Ian Ratcliffe, Paul Roderick, Louise Stanton, Nikhil Vergis, Mark Wright, Stephen Ryder, Ewan H. Forrest. Prednisolone or Pentoxifylline for Alcoholic Hepatitis. New England Journal of Medicine 2015; 372(17): 1619 doi: 10.1056/NEJMoa1412278
|
| 78 |
Alexandre Louvet, Philippe Mathurin. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nature Reviews Gastroenterology & Hepatology 2015; 12(4): 231 doi: 10.1038/nrgastro.2015.35
|
| 79 |
Ashwani K. Singal, Vijay H. Shah. Alcoholic Hepatitis: Prognostic Models and Treatment. Gastroenterology Clinics of North America 2011; 40(3): 611 doi: 10.1016/j.gtc.2011.06.008
|
| 80 |
Olivia C. Ahearn, Mia N. Watson, Scott M. Rawls. Chemokines, cytokines and substance use disorders. Drug and Alcohol Dependence 2021; 220: 108511 doi: 10.1016/j.drugalcdep.2021.108511
|
| 81 |
KASL Clinical Practice Guidelines: Management of Alcoholic Liver Disease. Clinical and Molecular Hepatology 2013; 19(3): 216 doi: 10.3350/cmh.2013.19.3.216
|
| 82 |
Phoenix Fung, Nikolaos Pyrsopoulos. Emerging concepts in alcoholic hepatitis. World Journal of Hepatology 2017; 9(12): 567-585 doi: 10.4254/wjh.v9.i12.567
|
| 83 |
Stelios F Assimakopoulos, Konstantinos C Thomopoulos, Chrisoula Labropoulou-Karatza. Pentoxifylline: A first line treatment option for severe alcoholic hepatitis and hepatorenal syndrome?. World Journal of Gastroenterology 2009; 15(25): 3194-3195 doi: 10.3748/wjg.15.3194
|
| 84 |
Erin K. J. Spengler, Jeffrey Dunkelberg, Ron Schey. Alcoholic Hepatitis: Current Management. Digestive Diseases and Sciences 2014; 59(10): 2357 doi: 10.1007/s10620-014-3173-8
|
| 85 |
|
| 86 |
Sarit Uzzan, Abed N. Azab. Anti-TNF-α Compounds as a Treatment for Depression. Molecules 2021; 26(8): 2368 doi: 10.3390/molecules26082368
|
| 87 |
Lukas Van Melkebeke, Hannelie Korf, Emmanuel A. Tsochatzis, Schalk van der Merwe, Frederik Nevens, Jef Verbeek. Treatment of severe alcoholic hepatitis: A systematic review. Current Opinion in Pharmacology 2021; 60: 91 doi: 10.1016/j.coph.2021.06.011
|
| 88 |
Rajekar Harshal. Severe Alcoholic Hepatitis-optimizing Medical Management: Whether we need a Liver Transplant. Annals of Clinical Gastroenterology and Hepatology 2024; 8(1): 006 doi: 10.29328/journal.acgh.1001045
|
| 89 |
Anurag Lavekar, Deepak Suvarna, Aradya V, Nandeesh P, Vijayakumar R, Rithesh Reddy. A Randomised Double-Blind Trial of Pentoxifylline Alone versus Pentoxifylline Plus N Acetyl Cysteine in the Treatment of Severe Alcoholic Hepatitis in a Tertiary Care Hospital in Mysore, Karnataka. Journal of Evidence Based Medicine and Healthcare 2021; 8(8): 399 doi: 10.18410/jebmh/2021/78
|
| 90 |
Marianna G. Mavilia, George Y. Wu. Pocket Handbook of GI Pharmacotherapeutics. Clinical Gastroenterology 2021; : 155 doi: 10.1007/978-3-030-72592-1_8
|
| 91 |
Faryal Tahir, Haris Riaz, Anis Rehman, Muhammad Bilal Munir. Potential role of TNF alpha blockers in delaying the progression of hepato-renal syndrome. Medical Hypotheses 2012; 78(2): 225 doi: 10.1016/j.mehy.2011.10.030
|
| 92 |
Mack C. Mitchell, Gyongyi Szabo. Schiff's Diseases of the Liver. 2017; : 699 doi: 10.1002/9781119251316.ch26
|
| 93 |
Reza Gholami, Rishad Khan, Anushka Ramkissoon, Abdulrahman Alabdulqader, Nikko Gimpaya, Rishi Bansal, Michael A Scaffidi, Vinay Prasad, Allan S Detsky, Jeffrey P Baker, Samir C Grover. Recommendation Reversals in Gastroenterology Clinical Practice Guidelines. Journal of the Canadian Association of Gastroenterology 2022; 5(2): 98 doi: 10.1093/jcag/gwab040
|
| 94 |
Jennifer Casanova, Ramón Bataller. Alcoholic hepatitis: Prognosis and treatment. Gastroenterología y Hepatología 2014; 37(4): 262 doi: 10.1016/j.gastrohep.2014.02.001
|
| 95 |
Seung Ha Park, Dong Joon Kim, Young Seok Kim, Hyung Joon Yim, Won Young Tak, Heon Ju Lee, Joo Hyun Sohn, Ki Tae Yoon, In Hee Kim, Hyoung Su Kim, Soon Ho Um, Soon Koo Baik, June Sung Lee, Ki Tae Suk, Sang Gyune Kim, Sang Jun Suh, Soo Young Park, Tae Yeob Kim, Jae Young Jang. Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: A randomised, non-inferiority, open trial. Journal of Hepatology 2014; 61(4): 792 doi: 10.1016/j.jhep.2014.05.014
|
| 96 |
Sandeep Singh Sidhu, Omesh Goyal, Preeti Singla, Dinesh Gupta, Ajit Sood, Rajoo Singh Chhina, Ravinder Kumar Soni. Corticosteroid Plus Pentoxifylline Is Not Better than Corticosteroid Alone for Improving Survival in Severe Alcoholic Hepatitis (COPE Trial). Digestive Diseases and Sciences 2012; 57(6): 1664 doi: 10.1007/s10620-012-2097-4
|
| 97 |
Ahmed A.M. Abdel-Hamid, Eyad M.T. Ali. Pentoxifylline attenuates hepatic fibrosis by inhibiting hepatic stellate cells. The Egyptian Journal of Histology 2015; 38(2): 378 doi: 10.1097/01.EHX.0000464787.34981.cc
|
| 98 |
Juan Caballeria. Is petoxifylline still an option in severe alcoholic hepatitis?. Hepatology 2015; 61(4): 1425 doi: 10.1002/hep.27657
|
| 99 |
|
| 100 |
Radan Bruha, Karel Dvorak, Jaromir Petrtyl. Alcoholic liver disease. World Journal of Hepatology 2012; 4(3): 81-90 doi: 10.4254/wjh.v4.i3.81
|
| 101 |
Hanieh Azizi, Nima Rouhani, Fatemeh Shaki, Elahe Karimpour-razkenari, Monireh Ghazaeian, Ebrahim Salehifar, Majid Saeedi, Sahar Fallah. Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial. International Immunopharmacology 2021; 101: 108227 doi: 10.1016/j.intimp.2021.108227
|
| 102 |
Juan Caballeria. ¿Tiene algún papel la pentoxifilina en el tratamiento de la hepatitis alcohólica?. Gastroenterología y Hepatología 2016; 39(8): 560 doi: 10.1016/j.gastrohep.2015.10.004
|
| 103 |
Walter E. Rodriguez, Banrida Wahlang, Yali Wang, Jingwen Zhang, Manicka V. Vadhanam, Swati Joshi‐Barve, Philip Bauer, Robert Cannon, Ali Reza Ahmadi, Zhaoli Sun, Andrew Cameron, Shirish Barve, Claudio Maldonado, Craig McClain, Leila Gobejishvili. Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench. Hepatology 2019; 70(6): 1958 doi: 10.1002/hep.30761
|
| 104 |
Apurva Yeluru, Jennifer A. Cuthbert, Lisa Casey, Mack C. Mitchell. Alcoholic Hepatitis: Risk Factors, Pathogenesis, and Approach to Treatment. Alcoholism: Clinical and Experimental Research 2016; 40(2): 246 doi: 10.1111/acer.12956
|
| 105 |
Verena Wieser, Herbert Tilg. Management bei schwerer alkoholischer Hepatitis. Wiener Medizinische Wochenschrift 2014; 164(1-2): 3 doi: 10.1007/s10354-013-0221-5
|
| 106 |
Ewan H Forrest. The management of alcoholic hepatitis. British Journal of Hospital Medicine 2009; 70(12): 680 doi: 10.12968/hmed.2009.70.12.45503
|
| 107 |
Ashutosh Barve, Luis S. Marsano, Dipendra Parajuli, Matthew Cave, Craig J. McClain. Liver Disorders. 2017; : 173 doi: 10.1007/978-3-319-30103-7_13
|